Hudson Bay Capital Management »

Apellis Pharmaceuticals shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $7.5M 260k 28.84
2024-06-30 $4.4M 115k 38.36
2024-03-31 $2.1M 35k 58.78
2023-09-30 $476k 13k 38.04
2023-03-31 $3.3M 50k 65.96
2020-09-30 $1.8M 60k 30.17

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Advanced Micro Devices Put Option (AMD)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Alphabet Cap Stk Cl C Put Option (GOOG)
Broadcom Call Option (AVGO)
New York Cmnty Bancorp Com New (FLG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Coinbase Global Com Cl A Put Option (COIN)
Dollar Tree Put Option (DLTR)

View all positions for Hudson Bay Capital Management

Top funds holding Apellis Pharmaceuticals

Wellington Management Company
EcoR1 Capital
venBio Select Advisor
Vanguard Group
BlackRock
Deep Track Capital
State Street Corporation
Jpmorgan Chase & Co
Braidwell
Octagon Capital Advisors
T. Rowe Price Investment Management
FMR
Jennison Associates
Siren
Geode Capital Management

View all funds holding Apellis Pharmaceuticals